Skip to Main Content

Paper Details

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
J Natl Cancer Inst
66
2021
21-gene, 21-gene assay, ESR1, HER2, HER2 RNA, Hormone Receptor, Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer, PGR, breast cancer, hormone, recurrence score, women
Author NameAffiliation
Matthew P GoetzMayo Clinic
Matthew J EllisBaylor College of Medicine
Ingrid A MayerVanderbilt University
  • 1 - 3

Datasets

Release 1.2